Related Experiment Video
Updated: Jun 21, 2025
04:01
Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
Published on: March 15, 2024
931
Current Progress of Ferroptosis Study in Hepatocellular Carcinoma
Xinyue Zhu1, Xudong Sha2, Yan Zang1
1Department of Clinical Laboratory, the First Affiliated Hospital of Anhui Medical University, Shushan District, No. 218 Jixi Road, Hefei, 230032, Anhui, China.
International Journal of Biological Sciences
|July 12, 2024
Summary
Ferroptosis, a cell death process driven by iron and lipid peroxidation, shows promise in cancer therapy. Inducing ferroptosis can inhibit tumor growth and enhance anti-cancer immune responses, particularly in hepatocellular carcinoma (HCC).
Area of Science:
- Biochemistry
- Cell Biology
- Oncology
Background:
- Ferroptosis is a distinct form of programmed cell death characterized by iron-dependent lipid peroxidation and reactive oxygen species (ROS) accumulation.
- Cancer cells, including those in hepatocellular carcinoma (HCC), exhibit heightened susceptibility to ferroptosis due to metabolic factors and ROS levels.
Purpose of the Study:
- To review the mechanisms underlying ferroptosis.
- To explore the role and therapeutic potential of ferroptosis in hepatocellular carcinoma (HCC).
Main Methods:
- Literature review of ferroptosis mechanisms and its involvement in cancer.
- Analysis of studies investigating ferroptosis induction as a cancer therapeutic strategy.
Main Results:
- Ferroptosis induction inhibits hepatoma cell growth and reverses tumorigenesis.
- Triggering ferroptosis enhances anti-tumor immunity and improves immunotherapy efficacy in HCC models.
Conclusions:
- Ferroptosis represents a promising therapeutic strategy for HCC.
- Targeting ferroptosis offers a novel approach to cancer treatment by inhibiting tumor progression and boosting immune responses.
